This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gu, Z.
Right arrow Articles by Matlashewski, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gu, Z.
Right arrow Articles by Matlashewski, G.

 Previous Article  |  Next Article 

J. Virol., Dec 1995, 8051-8056, Vol 69, No. 12
Copyright © 1995, American Society for Microbiology

Effect of human papillomavirus type 16 oncogenes on MAP kinase activity

Z Gu and G Matlashewski
Institute of Parasitology, McGill University, Ste. Anne de Bellevue, Quebec, Canada.

The mitogen-activated protein (MAP) kinase signal transduction pathway is an intracellular signaling cascade which mediates cellular responses to growth and differentiation factors. The MAP kinase pathway can be activated by a wide range of stimuli dependent on the cell types, and this is normally a transient response. Oncogenes such as ras, src, raf, and mos have been proposed to transform cells in part by prolonging the activated stage of components within this signaling pathway. The human papillomavirus (HPV) oncogenes E6 and E7 play an essential role in the in vitro transformation of primary human keratinocytes and rodent cells. The HPV type 16 E5 gene has also been shown to have weak transforming activity and may enhance the epidermal growth factor (EGF)- mediated signal transduction to the nucleus. In the present study, we have investigated the effects of the oncogenic HPV type 16 E5, E6, and E7 genes on the induction of the MAP kinase signaling pathway. The E5 gene induced an increase in the MAP kinase activity both in the absence and in the presence of EGF. In comparison, the E6 and E7 oncoproteins do not alter the MAP kinase activity or prolong the MAP kinase activity induced with EGF. These findings suggest that E5 may function, at least in part, to enhance the cell response through the MAP kinase pathway. However, the transforming activity of E6 and E7 is not associated with alterations in the MAP kinase pathway. These findings are consistent with E5 enhancing the response to growth factor stimulation.


This article has been cited by other articles:

  • Wang, Q., Kennedy, A., Das, P., McIntosh, P. B., Howell, S. A., Isaacson, E. R., Hinz, S. A., Davy, C., Doorbar, J. (2009). Phosphorylation of the Human Papillomavirus Type 16 E1^E4 Protein at T57 by ERK Triggers a Structural Change That Enhances Keratin Binding and Protein Stability. J. Virol. 83: 3668-3683 [Abstract] [Full Text]  
  • Maufort, J. P., Genther Williams, S. M., Pitot, H. C., Lambert, P. F. (2007). Human Papillomavirus 16 E5 Oncogene Contributes to Two Stages of Skin Carcinogenesis. Cancer Res. 67: 6106-6112 [Abstract] [Full Text]  
  • Yu, J.-H., Lin, B. Y., Deng, W., Broker, T. R., Chow, L. T. (2007). Mitogen-Activated Protein Kinases Activate the Nuclear Localization Sequence of Human Papillomavirus Type 11 E1 DNA Helicase To Promote Efficient Nuclear Import. J. Virol. 81: 5066-5078 [Abstract] [Full Text]  
  • McCance, D. J. (2005). Human Papillomaviruses and Cell Signaling. Sci Signal 2005: pe29-pe29 [Abstract] [Full Text]  
  • Disbrow, G. L., Hanover, J. A., Schlegel, R. (2005). Endoplasmic Reticulum-Localized Human Papillomavirus Type 16 E5 Protein Alters Endosomal pH but Not trans-Golgi pH. J. Virol. 79: 5839-5846 [Abstract] [Full Text]  
  • Fehrmann, F., Klumpp, D. J., Laimins, L. A. (2003). Human Papillomavirus Type 31 E5 Protein Supports Cell Cycle Progression and Activates Late Viral Functions upon Epithelial Differentiation. J. Virol. 77: 2819-2831 [Abstract] [Full Text]  
  • Genther, S. M., Sterling, S., Duensing, S., Munger, K., Sattler, C., Lambert, P. F. (2003). Quantitative Role of the Human Papillomavirus Type 16 E5 Gene during the Productive Stage of the Viral Life Cycle. J. Virol. 77: 2832-2842 [Abstract] [Full Text]  
  • Zhang, B., Spandau, D. F., Roman, A. (2002). E5 Protein of Human Papillomavirus Type 16 Protects Human Foreskin Keratinocytes from UV B-Irradiation-Induced Apoptosis. J. Virol. 76: 220-231 [Abstract] [Full Text]  
  • Kulkarni, S., Rader, J. S., Zhang, F., Liapis, H., Koki, A. T., Masferrer, J. L., Subbaramaiah, K., Dannenberg, A. J. (2001). Cyclooxygenase-2 Is Overexpressed in Human Cervical Cancer. Clin. Cancer Res. 7: 429-434 [Abstract] [Full Text]  
  • Hausen, H. z. (2000). Papillomaviruses Causing Cancer: Evasion From Host-Cell Control in Early Events in Carcinogenesis. JNCI J Natl Cancer Inst 92: 690-698 [Abstract] [Full Text]  
  • Albrecht, J.-C., Friedrich, U., Kardinal, C., Koehn, J., Fleckenstein, B., Feller, S. M., Biesinger, B. (1999). Herpesvirus Ateles Gene Product Tio Interacts with Nonreceptor Protein Tyrosine Kinases. J. Virol. 73: 4631-4639 [Abstract] [Full Text]  
  • Fischer, R. S., Quinlan, M. P. (1998). Expression of the pRb-Binding Regions of E1A Enables Efficient Transformation of Primary Epithelial Cells by v-src. J. Virol. 72: 2815-2824 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»